%0 journal article
%@ 1932-6203
%A Xu, Z., Neuber, S., Nazari-Shafti, T., Liu, Z., Dong, F., Stamm, C.

%D 2022
%J PLoS One
%N 1
%P e0261462 
%R doi:10.1371/journal.pone.0261462
%T Impact of procedural variability and study design quality on the efficacy of cell-based therapies for heart failure - a meta-analysis
%U https://doi.org/10.1371/journal.pone.0261462
1 
%X The published results suggest a small increase in LVEF following cell therapy for heart failure, but publication bias and methodologic shortcomings need to be taken into account. Given that cardiac cell therapy has now been pursued for 20 years without real progress, further efforts should not be made.